Neuro-Oncology Research

The UCLA Neuro-oncology Program conducts extensive translational and clinical research focused on individualizing treatments to extend and improve the lives of patients with primary brain tumors. The program faculty members often collaborate with other investigators in the UCLA Brain Tumor Center and are part of the brain cancer SPORE.

Basic and Translational Research:
UCLA Brain Tumor Center Research

Additional Information - Neuro-Oncology Program:
Neuro-Oncology Program
The Lai Lab

Clinical Trials

Neuro-Oncology clinical trials include advanced treatment modalities for brain cancer including targeted therapies, viral therapies, and immunotherapies. Other clinical trials include studies in tumor imaging, quality of care, and neurocognition in collaboration with other researchers at UCLA Health.

For questions on clinical trials, contact:
Emese Filka
Clinical Trial Coordinator
310-794-3521

You may find more information on the following clinical trials offered by our program at ClinicalTrials.gov

UCLA - IRB Number	Study Agent	Targeted Pathology Diagnosis	Trial Phase
#19-001010	Control Arm with Treatment of RT/TMZ	Newly Diagnosed GBM and Recurrent GBM	Phase 2/3
#19-001010	Regorafenib Arm	Newly Diagnosed GBM and Recurrent GBM	Phase 2/3
#19-001010	Paxalisib Arm	Newly Diagnosed GBM and Recurrent GBM	Phase 2/3
#19-001010	Val-083 Arm	Newly Diagnosed GBM and Recurrent GBM	Phase 2/3
#19-001090	ATL-DC and Pembrolizumab with surgery	1st or 2nd Recurrent GBM	Phase 1
#20-001227	VB-111 with surgery	1st or 2nd Recurrent GBM	Phase 2
#21-001441	Icapamespib (PU-AD)	Recurrent GBM or Grade 3 or 4 astrocytoma	Phase 1
#20-001181	Brigatinib	Patients with Neurofibromatosis Type 2	Phase 2